Clinical trial
Evaluation of the Efficacy and Safety of Low-Dose Propranolol Combined With Intralesional Bleomycin for Infantile Hemangioma: A Randomized Controlled Trial
NCT07104526 is registered in ClinicalTrials.gov with Wuhan Integrated Traditional Chinese and Western Medicine Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Efficacy and Safety of Low-Dose Propranolol Combined With Intralesional Bleomycin for Infantile Hemangioma: A Randomized Controlled Trial
- Lead sponsor
- Wuhan Integrated Traditional Chinese and Western Medicine Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 1, 2024
- Completion date
- January 1, 2025
- Enrollment
- 260 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
infantile hemangioma (ih)